Evidence map›Paper›PMID 16809326›Full record

ArticleJournal of virology2006

Transmission of simian immunodeficiency virus SIVcpz and the evolution of infection in the presence and absence of concurrent human immunodeficiency virus type 1 infection in chimpanzees.

Jonathan L Heeney, Erik Rutjens, Ernst J Verschoor, Henk Niphuis, Peter ten Haaft, Scott Rouse, Hazel McClure, Sunita Balla-Jhagjhoorsingh, Willy Bogers, Mary Salas and 7 more

Abstract read
In one paragraph

Article in Journal of virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. CD4 receptor diversity in chimpanzees protects against SIV infection.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Origins of HIV and the AIDS pandemic.Cold Spring Harbor perspectives in medicine · 2011
    Review
  10. Article
  11. AIDS-protective HLA-B*27/B*57 and chimpanzee MHC class I molecules target analogous conserved areas of HIV-1/SIVcpz.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jonathan L HeeneyDepartment of Virology, Biomedical Primate Research Centre, Lange Kleiweg 139, P.O. Box 3306, 2280 GH Rijswijk, The Netherlands. heeney@bprc.nl
Erik Rutjens
Ernst J Verschoor
Henk Niphuis
Peter ten Haaft
Scott Rouse
Hazel McClure
Sunita Balla-Jhagjhoorsingh
Willy Bogers
Mary Salas
Kathy Cobb
Luc Kestens
David Davis
Guido van der Groen
Valerie Courgnaud
Martine Peeters
Krishna K Murthy

Funding

MAINTENANCE OF CHIMPANZEES FOR HEPATITIS/AIDS RESEARCHN01HB027091 · HB · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI MURTHY, KRISHNA K · 1992 to 2000
$290k
NHLBI NIH HHS N01 HB027091
6 · The paper itself

Abstract

Current data suggest that the human immunodeficiency virus type 1 (HIV-1) epidemic arose by transmission of simian immunodeficiency virus (SIV) SIVcpz from a subspecies of common chimpanzees (Pan troglodytes troglodytes) to humans. SIVcpz of chimpanzees is itself a molecular chimera of SIVs from two or more different monkey species, suggesting that recombination was made possible by coinfection of one individual animal with different lentiviruses. However, very little is known about SIVcpz transmission and the susceptibility to lentivirus coinfection of its natural host, the chimpanzee. Here, it is revealed that either infected plasma or peripheral blood mononuclear cells readily confer infection when exposure occurs by the intravenous or mucosal route. Importantly, the presence of preexisting HIV-1 infection did not modify the kinetics of SIVcpz infection once it was established by different routes. Although humoral responses appeared as early as 4 weeks postinfection, neutralization to SIVcpz-ANT varied markedly between animals. Analysis of the SIVcpz env sequence over time revealed the emergence of genetic viral variants and persistent SIVcpz RNA levels of between 10(4) and 10(5) copies/ml plasma regardless of the presence or absence of concurrent HIV-1 infection. These unique data provide important insight into possible routes of transmission, the kinetics of acute SIVcpz infection, and how readily coinfection with SIVcpz and other lentiviruses may be established as necessary preconditions for potential recombination.

Indexed as

HIV-1Simian Immunodeficiency VirusAnimalsApe DiseasesChimeraEvolution, MolecularGene Products, envHIV AntibodiesHIV InfectionsPan troglodytesRecombination, GeneticRNA, ViralSimian Acquired Immunodeficiency SyndromeSpecies SpecificityGene Products, envHIV AntibodiesRNA, Viral

Identifiers

PMID16809326
PMCPMC1489021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.